SPARC expression by cerebral microvascular endothelial cells in vitro and its influence on blood-brain barrier properties
Open Access
- 31 August 2016
- journal article
- research article
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 13 (1) , 1-17
Abstract
SPARC (secreted protein acidic and rich in cysteine) is a nonstructural, cell-matrix modulating protein involved in angiogenesis and endothelial barrier function, yet its potential role in cerebrovascular development, inflammation, and repair in the central nervous system (CNS) remains undetermined. This study examines SPARC expression in cultured human cerebral microvascular endothelial cells (hCMEC/D3)—an in vitro model of the blood-brain barrier (BBB)—as they transition between proliferative and barrier phenotypes and encounter pro-inflammatory stimuli. SPARC protein levels were quantified by Western blotting and immunocytochemistry and messenger RNA (mRNA) by RT-PCR. Constitutive SPARC expression by proliferating hCMEC/D3s is reduced as cells mature and establish a confluent monolayer. SPARC expression positively correlated with the proliferation marker Ki-67 suggesting a role for SPARC in cerebrovascular development. The pro-inflammatory molecules tumor necrosis factor-α (TNF-α) and endotoxin lipopolysaccharide (LPS) increased SPARC expression in cerebral endothelia. Interferon gamma (IFN-γ) abrogated SPARC induction observed with TNF-α alone. Barrier function assays show recombinant human (rh)-SPARC increased paracellular permeability and decreased transendothelial electrical resistance (TEER). This was paralleled by reduced zonula occludens-1 (ZO-1) and occludin expression in hCMEC/D3s exposed to rh-SPARC (1–10 μg/ml) compared with cells in media containing a physiological dose of SPARC. Together, these findings define a role for SPARC in influencing cerebral microvascular properties and function during development and inflammation at the BBB such that it may mediate processes of CNS inflammation and repair.Keywords
Funding Information
- University of British Columbia
- Canadian Institutes of Health Research
This publication has 55 references indexed in Scilit:
- TNF-α Signals Through PKCζ/NF-κB to Alter the Tight Junction Complex and Increase Retinal Endothelial Cell PermeabilityDiabetes, 2010
- Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumorsMolecular Cancer, 2010
- VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdownProceedings of the National Academy of Sciences, 2009
- The counteradhesive proteins, thrombospondin 1 and SPARC/osteonectin, open the tyrosine phosphorylation-responsive paracellular pathway in pulmonary vascular endotheliaMicrovascular Research, 2009
- SPARC‐induced increase in glioma matrix and decrease in vascularity are associated with reduced VEGF expression and secretionInternational Journal of Cancer, 2008
- Differential effects of hydrocortisone and TNFα on tight junction proteins in an in vitro model of the human blood–brain barrierThe Journal of Physiology, 2008
- Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cellsBrain Research, 2007
- Distribution of SPARC during neovascularisation of degenerative aortic stenosisHeart, 2006
- Induction of SPARC by VEGF in Human Vascular Endothelial CellsBiochemical and Biophysical Research Communications, 2001
- Radioimmunoassay for osteonectin. Concentrations in bone, nonmineralized tissues, and bloodJournal of Bone and Mineral Research, 1987